Third, retinoic acid could inhibit pancreatic cancer cell migration and epithelial-mesenchymal transition by decreasing the expression of interleukin 6 in cancer-associated fibroblast cells, suggesting that retinoids could be applied to prevention or therapy in the recurrence and metastasis of pancreatic cancer [58]. This evidence concerns the gene IL6 and familial pancreatic carcinoma.